Faes Farma SA
MAD:FAE
Faes Farma SA?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3.29
4.21
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Faes Farma SA hold over its rivals?
What risks and challenges
does Faes Farma SA face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Faes Farma SA.
Provide an overview of the primary business activities
of Faes Farma SA.
What unique competitive advantages
does Faes Farma SA hold over its rivals?
What risks and challenges
does Faes Farma SA face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Faes Farma SA.
Provide P/S
for Faes Farma SA.
Provide P/E
for Faes Farma SA.
Provide P/OCF
for Faes Farma SA.
Provide P/FCFE
for Faes Farma SA.
Provide P/B
for Faes Farma SA.
Provide EV/S
for Faes Farma SA.
Provide EV/GP
for Faes Farma SA.
Provide EV/EBITDA
for Faes Farma SA.
Provide EV/EBIT
for Faes Farma SA.
Provide EV/OCF
for Faes Farma SA.
Provide EV/FCFF
for Faes Farma SA.
Provide EV/IC
for Faes Farma SA.
Show me price targets
for Faes Farma SA made by professional analysts.
What are the Revenue projections
for Faes Farma SA?
How accurate were the past Revenue estimates
for Faes Farma SA?
What are the Net Income projections
for Faes Farma SA?
How accurate were the past Net Income estimates
for Faes Farma SA?
What are the EPS projections
for Faes Farma SA?
How accurate were the past EPS estimates
for Faes Farma SA?
What are the EBIT projections
for Faes Farma SA?
How accurate were the past EBIT estimates
for Faes Farma SA?
Compare the revenue forecasts
for Faes Farma SA with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Faes Farma SA and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Faes Farma SA against its competitors.
Analyze the profit margins
(gross, operating, and net) of Faes Farma SA compared to its peers.
Compare the P/E ratios
of Faes Farma SA against its peers.
Discuss the investment returns and shareholder value creation
comparing Faes Farma SA with its peers.
Analyze the financial leverage
of Faes Farma SA compared to its main competitors.
Show all profitability ratios
for Faes Farma SA.
Provide ROE
for Faes Farma SA.
Provide ROA
for Faes Farma SA.
Provide ROIC
for Faes Farma SA.
Provide ROCE
for Faes Farma SA.
Provide Gross Margin
for Faes Farma SA.
Provide Operating Margin
for Faes Farma SA.
Provide Net Margin
for Faes Farma SA.
Provide FCF Margin
for Faes Farma SA.
Show all solvency ratios
for Faes Farma SA.
Provide D/E Ratio
for Faes Farma SA.
Provide D/A Ratio
for Faes Farma SA.
Provide Interest Coverage Ratio
for Faes Farma SA.
Provide Altman Z-Score Ratio
for Faes Farma SA.
Provide Quick Ratio
for Faes Farma SA.
Provide Current Ratio
for Faes Farma SA.
Provide Cash Ratio
for Faes Farma SA.
What is the historical Revenue growth
over the last 5 years for Faes Farma SA?
What is the historical Net Income growth
over the last 5 years for Faes Farma SA?
What is the current Free Cash Flow
of Faes Farma SA?
Discuss the annual earnings per share (EPS)
trend over the past five years for Faes Farma SA.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
ES |
F
|
Faes Farma SA
MAD:FAE
|
1.3B EUR | 2.7 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
846.5B USD | 18.9 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
376B USD | 4.2 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.9T DKK | 6.7 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
214.9B CHF | 3.6 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
189.9B CHF | 4.5 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
166.3B GBP | 4.1 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
215.4B USD | 3.4 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD | 70.5 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
138.3B USD | 2.2 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
ES |
F
|
Faes Farma SA
MAD:FAE
|
Average P/S:
63.5
2.7
|
9%
|
0.3 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
18.9
|
23%
|
0.8 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
578.3
|
9%
|
64.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
4.2
|
4%
|
1.1 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
6.7
|
16%
|
0.4 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
3.6
|
5%
|
0.7 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
4.5
|
3%
|
1.5 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
4.1
|
7%
|
0.6 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
3.4
|
5%
|
0.7 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
70.5
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
2.2
|
-1%
|
N/A |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.